Real-World Study of Everolimus in Advanced Progressive Neuroendocrine TumorsFrancesco Panzuto, Gianfranco Delle Fave, Maria Rinzivillo et al.|The Oncologist|2014Cited by 103
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national databaseFrancesco Panzuto, Massimo Falconi, Stefano Partelli et al.|Endocrine|2024Cited by 19
Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancerAndrea Prodosmo, Silvia Soddu, Amelia Buffone et al.|Journal of Experimental & Clinical Cancer Research|2016Cited by 12
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine TumorsFrancesco Panzuto, Gianfranco Delle Fave, Maria Rinzivillo et al.|The Oncologist|2015Cited by 9
Impact of dyslipidemia and lipid‐lowering therapy with statins in patients with neuroendocrine tumorsAntongiulio Faggiano, Annamaria Colao, Elisa Giannetta et al.|Journal of Neuroendocrinology|2024Cited by 4